Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
Sovesh MohapatraPrathul NathManisha ChatterjeeNeeladrisingha DasDeepjyoti KalitaPartha RoySoumitra SatapathiPublished in: PloS one (2020)
Our study can help clinical scientists in being more selective in identifying and testing the therapeutic agents for COVID-19 treatment. The ML based approach for drug discovery as reported here can be a futuristic smart drug designing strategy for community applications.